Mach7 Technologies Ltd
ASX:M7T
Intrinsic Value
Mach7 Technologies Ltd. provides medical imaging software and services for healthcare institutions. [ Read More ]
The intrinsic value of one
M7T
stock under the Base Case scenario is
0.44
AUD.
Compared to the current market price of 0.74 AUD,
Mach7 Technologies Ltd
is
Overvalued by 40%.
Mach7 Technologies Ltd's market capitalization is 178.5m AUD.
M7T stock price is 0.74 AUD.
M7T stock (0.44 AUD) is 40% less than its price (0.74 AUD).
M7T has upside potential of 76% compared to the average analyst price target.
Open Wall St Estimates
M7T's Revenue has dropped by 8% over the past 12 months.
M7T's ROE (Return on Equity) has increased in the last 3 years from -18% to -10%, and is approaching profitability.
M7T's ROIC (Return on Invested Capital) has increased in the last 3 years from -19% to -12%, and is approaching profitability.
M7T's Revenue is forecast to grow at a rate of 16% per year over the next 3 years.
M7T has positive Free Cash Flow for the last twelve months.
M7T's Revenue has been growing by 17% per year for the last 3 years.
M7T's ROE (Return on Equity) for the past 12 months is negative and is equal to -10%.
M7T's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -12%.
M7T has negative Operating Income for the last twelve months.
M7T has negative Net Income for the last twelve months.
M7T's short-term assets (32m AUD) exceed its short-term liabilties (13m AUD).
M7T has positive Gross Profit for the last twelve months.
M7T has negative three-year average ROE (Return on Equity): -9%. The company is not efficient at transforming stockholders' equity into net income.
M7T has negative three-year average ROIC (Return on Invested Capital): -12%. The company is not efficient at using invested capital to generate operating income.
M7T's long-term assets (74m AUD) exceed its long-term liabilties (19m AUD).
M7T's D/E (Debt to Equity) is very low and is equal to 0.02.
M7T has negative Net Debt. This means that the company has more cash and short-term investments (23m AUD) than debt (855k AUD).
M7T's Altman Z-Score is very high and is equal to 4.51.
Valuation Backtest
Mach7 Technologies Ltd
Run backtest to discover the historical profit from buying and selling
M7T
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Mach7 Technologies Ltd
Balance Sheet Decomposition
Mach7 Technologies Ltd
| Current Assets | 31.7m |
| Cash & Short-Term Investments | 22.7m |
| Receivables | 8m |
| Other Current Assets | 952.4k |
| Non-Current Assets | 42.1m |
| PP&E | 1.8m |
| Intangibles | 31.2m |
| Other Non-Current Assets | 9.1m |
| Current Liabilities | 12.6m |
| Accounts Payable | 2.4m |
| Other Current Liabilities | 10.1m |
| Non-Current Liabilities | 6.8m |
| Long-Term Debt | 855.4k |
| Other Non-Current Liabilities | 5.9m |
Earnings Waterfall
Mach7 Technologies Ltd
|
Revenue
|
27m
AUD
|
|
Cost of Revenue
|
-1.3m
AUD
|
|
Gross Profit
|
25.6m
AUD
|
|
Operating Expenses
|
-37.4m
AUD
|
|
Operating Income
|
-11.8m
AUD
|
|
Other Expenses
|
6.2m
AUD
|
|
Net Income
|
-5.6m
AUD
|
Free Cash Flow Analysis
Mach7 Technologies Ltd
M7T Profitability Score
Profitability Due Diligence
Mach7 Technologies Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
Mach7 Technologies Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
M7T Solvency Score
Solvency Due Diligence
Mach7 Technologies Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
Mach7 Technologies Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
M7T Price Targets Summary
Mach7 Technologies Ltd
According to Wall Street analysts, the average 1-year price target for
M7T
is 1.3 AUD
with a low forecast of 1.06 AUD and a high forecast of 1.64 AUD.
Shareholder Return
M7T Price
Mach7 Technologies Ltd
| Average Annual Return | 45.74% |
| Standard Deviation of Annual Returns | 88.18% |
| Max Drawdown | -71% |
| Market Capitalization | 178.5m AUD |
| Shares Outstanding | 241 241 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Mach7 Technologies Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Mach7 Technologies Ltd. provides medical imaging software and services for healthcare institutions. The company is headquartered in Melbourne, Victoria and currently employs 90 full-time employees. The company went IPO on 2005-11-30. The principal activities of the Company include the provision of enterprise imaging data sharing, storage and interoperability for healthcare enterprises globally. The firm operates through two segments: sale of software and rendering of professional services. The sale of software segment engaged in selling software licenses. The provision of the software license is a distinct performance obligation as the customer can derive substantial benefits from the license on its own when the license is delivered and installed. Healthcare enterprises globally segment engaged in providing professional services, such as implementation, training and annual support services. The firm provides various solutions, including Enterprise Diagnostic Viewing, Enterprise Data Management and Enterprise PACS.
Contact
IPO
Employees
Officers
The intrinsic value of one
M7T
stock under the Base Case scenario is
0.44
AUD.
Compared to the current market price of 0.74 AUD,
Mach7 Technologies Ltd
is
Overvalued by 40%.
You don't have any saved screeners yet
